QIAGEN NV Pricing & Demo

Are you from this Company?
QIAGEN NV
Write a Review
Hilden, Germany
1984
$1BN to $5BN
Enterprise
95 Likes
75 Buyers Negotiating
Summary
No Summary And Details

Popular Comparisons

Discussions

Strengths
  • +8
    New Liquid Biopsy Products launched in the last four years
  • +5
    Therapy Selection
  • +13
    Clinical Use
  • +14
    Assay kits
  • +7
    Blood
  • +9
    Circulating Tumor Cells (CTCs)
  • +10
    Circulating Tumor DNA (ctDNA)
  • +5
    Instruments
  • +14
    Breadth and Depth of Product Offerings
  • +6
    Focus on Product Innovation
  • +7
    Product Differentiation and Impact on Customer Value
  • +5
    Product Features and Functionality
  • +6
    Services
  • +11
    Cell-Free DNA (cfDNA)
  • +12
    Research Use
  • +8
    Urine
  • +9
    Others (Saliva, other body fluids)
  • +12
    Extracellular Vesicles (EVs)
  • +6
    Treatment Monitoring
  • +14
    Early Cancer Screening
Cautions
  • -13
    Other Circulating Biomarkers
  • -7
    Recurrence Monitoring
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup
logo-360
  • saved

    You haven’t saved anything yet

    To save, search for Vendors by
    Name or Category, then tap the heart